CYCLOPENTANESULFONYL CHLORIDE

CAS26394-17-2

CYCLOPENTANESULFONYL CHLORIDE (CAS 26394-17-2, C5H9 Cl O2 S) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of CYCLOPENTANESULFONYL CHLORIDE
C5H9 Cl O2 S · 168.64 g/mol
CAS No.
26394-17-2
Formula
C5H9 Cl O2 S
Mol. weight
168.64 g/mol

Chemical Specifications

Identifiers

CAS number 26394-17-2
Product name CYCLOPENTANESULFONYL CHLORIDE
Chinese name 环戊烷磺酰氯
Synonyms CYCLOPENTANESULFONYL CHLORIDE
Chinese synonyms 环戊烷磺酰氯; 环戊基磺酰氯
Molecular formula C5H9 Cl O2 S
Molecular weight 168.64 g/mol
InChI InChI=1/C5H9ClO2S/c6-9(7,8)5-3-1-2-4-5/h5H,1-4H2

Physical and chemical properties

Boiling Point 96.9 ( ℃ )

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of CYCLOPENTANESULFONYL CHLORIDE?

The CAS Registry Number of CYCLOPENTANESULFONYL CHLORIDE is 26394-17-2. CYCLOPENTANESULFONYL CHLORIDE is also known as CYCLOPENTANESULFONYL CHLORIDE.

What is the molecular formula and molecular weight of CYCLOPENTANESULFONYL CHLORIDE?

The molecular formula of CYCLOPENTANESULFONYL CHLORIDE is C5H9 Cl O2 S, and its molecular weight is 168.64 g/mol.

How can I request a quotation for CYCLOPENTANESULFONYL CHLORIDE?

Send an inquiry for CYCLOPENTANESULFONYL CHLORIDE (CAS 26394-17-2) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for CYCLOPENTANESULFONYL CHLORIDE

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.